EQUITY ALERT: The Rosen Law Firm Announces the Filing of a Securities Class Action Against Aerie Pharmaceuticals, Inc.

The Rosen Law Firm, a global investor rights firm, announces that a class action lawsuit has been filed on behalf of purchasers of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) securities from August 6, 2014 through April 23, 2015 (the “Class Period”). The lawsuit seeks to recover damages for Aerie investors under the federal securities laws.

To join the Aerie class action, go to the firm’s website at http://www.rosenlegal.com/cases-588.html or call Phillip Kim, Esq. or Jonathan Horne, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or jhorne@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

The lawsuit alleges that during the Class Period defendants made false and/or misleading statements and/or failed to disclose adverse information regarding the Company’s prospects for its lead product candidate, RhopressaTM (“Rhopressa”). On April 23, 2015, the Company issued a press release announcing the results of its first Phase 3 registration trial for Rhopressa. According to the release, “[t]he trial did not meet its primary efficacy endpoint of demonstrating non-inferiority of IOP lowering for once-daily RhopressaTM compared to twice-daily timolol, the most widely used comparator in registration trials for glaucoma.” On this news, shares of Aerie fell $22.52 per share to close at $12.87 per share on April 24, 2015.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 29, 2015. If you wish to join the litigation, go to the firm’s website at http://www.rosenlegal.com/cases-588.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Jonathan Horne, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or jhorne@rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.